Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Buring

Showing results (81-90 of 188) with videos related to

Pageof 19
Sort By:
Archives of Internal Medicine|November 1, 1992
Occupation and risk of nonfatal myocardial infarctionP R Hebert, J E Buring, G T O'Connor, et al.
Stroke|January 8, 1999
Exercise and risk of stroke in male physiciansI M Lee, C H Hennekens, K Berger, et al.
JAMA|September 24, 1999
Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trialS Liu, U Ajani, C Chae, et al.
JAMA|July 24, 2001
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitusA D Pradhan, J E Manson, N Rifai, et al.
The American Journal of Medicine|March 1, 1984
Interruption of the inferior vena cava by clip or filterS Z Goldhaber, J E Buring, R J Lipnick, et al.
Journal of Internal Medicine|December 12, 2007
Renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms are not associated with the risk of incident type 2 diabetes mellitus: a prospective cohort studyD Conen, R J Glynn, J E Buring, et al.
Circulation|August 18, 1999
Hormone replacement therapy and increased plasma concentration of C-reactive proteinP M Ridker, C H Hennekens, N Rifai, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 11, 2011
Association between modifiable lifestyle factors and residual lifetime risk of diabetesL Djoussé, J A Driver, J M Gaziano, et al.
European Journal of Neurology|October 5, 2012
Biomarkers and functional outcomes from ischaemic cerebral events in women: a prospective cohort studyP M Rist, J E Buring, C S Kase, et al.
Journal of Cardiovascular Risk|April 1, 1996
Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and womenP M Ridker, C H Hennekens, G H Tofler, et al.
Pageof 19

Showing results (81-90 of 188) with videos related to

Sort By:
Pageof 19
Archives of Internal Medicine|November 1, 1992
Occupation and risk of nonfatal myocardial infarctionP R Hebert, J E Buring, G T O'Connor, et al.
Stroke|January 8, 1999
Exercise and risk of stroke in male physiciansI M Lee, C H Hennekens, K Berger, et al.
JAMA|September 24, 1999
Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trialS Liu, U Ajani, C Chae, et al.
JAMA|July 24, 2001
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitusA D Pradhan, J E Manson, N Rifai, et al.
The American Journal of Medicine|March 1, 1984
Interruption of the inferior vena cava by clip or filterS Z Goldhaber, J E Buring, R J Lipnick, et al.
Journal of Internal Medicine|December 12, 2007
Renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms are not associated with the risk of incident type 2 diabetes mellitus: a prospective cohort studyD Conen, R J Glynn, J E Buring, et al.
Circulation|August 18, 1999
Hormone replacement therapy and increased plasma concentration of C-reactive proteinP M Ridker, C H Hennekens, N Rifai, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 11, 2011
Association between modifiable lifestyle factors and residual lifetime risk of diabetesL Djoussé, J A Driver, J M Gaziano, et al.
European Journal of Neurology|October 5, 2012
Biomarkers and functional outcomes from ischaemic cerebral events in women: a prospective cohort studyP M Rist, J E Buring, C S Kase, et al.
Journal of Cardiovascular Risk|April 1, 1996
Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and womenP M Ridker, C H Hennekens, G H Tofler, et al.
Pageof 19